Skip to Main Content

Paper Details

Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.
Lancet
182
2019
angiotensin receptor, angiotensin-converting enzyme, calcium, dihydropyridine, heart failure, hypertension, myocardial infarction, patients, stroke, thiazide
Author NameAffiliation
Marc A SuchardFielding School of Public Health, University of California, David Geffen School of Medicine at university of california los angeles
Marc A SuchardFielding School of Public Health, University of California, David Geffen School of Medicine at university of california los angeles
Martijn J SchuemieFielding School of Public Health, University of California los angeles
Martijn J SchuemieFielding School of Public Health, University of California los angeles
Harlan M KrumholzYale University School of Medicine
Harlan M KrumholzYale University School of Medicine
Seng Chan YouAjou University School of Medicine
Seng Chan YouAjou University School of Medicine
Ruijun ChenWeill Cornell Medical College, Columbia University Medical Center
Nicole L PrattQuality Use of Medicines and Pharmacy Research Centre, Sansom Institute, University of South Australia
Nicole L PrattQuality Use of Medicines and Pharmacy Research Centre, Sansom Institute, University of South Australia
Christian Reich
Christian Reich
Jon DukeGeorgia Tech Research Institute, Georgia Tech College of Computing
Jon DukeGeorgia Tech Research Institute, Georgia Tech College of Computing
David MadiganColumbia University
David MadiganColumbia University
George HripcsakColumbia University Medical Center, New York-Presbyterian Hospital
George HripcsakColumbia University Medical Center, New York-Presbyterian Hospital
Patrick B RyanColumbia University Medical Center
Patrick B RyanColumbia University Medical Center
  • 1 - 21

Datasets